Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation¹.

Treatment of these complications can be expensive², yet many are avoidable³, making early identification and intervention key to improving patient outcomes and reducing health costs.

Neuropen® is the only peripheral neuropathy screening device incorporating pressure and sharpness tests, giving clinicians a simple, compact solution for testing large and small nerve fibres in the foot.

Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments.

Neuropen® is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual-purpose, pocket-sized device designed to provide a safe and reliable test.

How Neuropen® works

The Neuropen® is a reusable device that can deliver:

• A 10g pressure test using Neuropen® Monofilaments to assess any reduction in sensation in the tested area.
• A 40g sharpness test using Neurotips single-use neurological examination pins to assess reduced sensation to sharpness or pain in small nerve fibres.